These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 9733452

  • 41. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY, Lu LJ, Li FH, Li HL, Gu YY, Chen SL, Bao CD.
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [Abstract] [Full Text] [Related]

  • 42. Cigarette smoking and cutaneous damage in systemic lupus erythematosus.
    Turchin I, Bernatsky S, Clarke AE, St-Pierre Y, Pineau CA.
    J Rheumatol; 2009 Dec; 36(12):2691-3. PubMed ID: 19884279
    [Abstract] [Full Text] [Related]

  • 43. Fatigue in lupus is not correlated with disease activity.
    Wang B, Gladman DD, Urowitz MB.
    J Rheumatol; 1998 May; 25(5):892-5. PubMed ID: 9598886
    [Abstract] [Full Text] [Related]

  • 44. A comparison of prospective and retrospective evaluations of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus.
    Bernatsky S, Clarke A, Abrahamowicz M, Neville C, Karp I, Pineau CA.
    J Rheumatol; 2005 May; 32(5):820-3. PubMed ID: 15868615
    [Abstract] [Full Text] [Related]

  • 45. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus.
    Stoll T, Gordon C, Seifert B, Richardson K, Malik J, Bacon PA, Isenberg DA.
    J Rheumatol; 1997 Aug; 24(8):1608-14. PubMed ID: 9263159
    [Abstract] [Full Text] [Related]

  • 46. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
    Ward MM, Marx AS, Barry NN.
    J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
    [Abstract] [Full Text] [Related]

  • 47. Alexithymia in systemic lupus erythematosus patients.
    Barbosa F, Mota C, Alves M, Alcântara C, Rossiñol B, Patrício P, Barbosa A, Ferreira C.
    Ann N Y Acad Sci; 2009 Sep; 1173():227-34. PubMed ID: 19758155
    [Abstract] [Full Text] [Related]

  • 48. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
    Uribe AG, Vilá LM, McGwin G, Sanchez ML, Reveille JD, Alarcón GS.
    J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
    Mikdashi J, Handwerger B.
    Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus.
    Oeser A, Chung CP, Asanuma Y, Avalos I, Stein CM.
    Arthritis Rheum; 2005 Nov; 52(11):3651-9. PubMed ID: 16258902
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study.
    Appenzeller S, Pereira DA, Costallat LT.
    Lupus; 2008 Nov; 17(11):1023-8. PubMed ID: 18852227
    [Abstract] [Full Text] [Related]

  • 55. The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected].
    Chaiamnuay S, Bertoli AM, Fernández M, Apte M, Vilá LM, Reveille JD, Alarcón GS, LUMINA Study Group.
    J Clin Rheumatol; 2007 Jun; 13(3):128-33. PubMed ID: 17551377
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. The relationship between socioeconomic status and recently diagnosed rheumatoid arthritis.
    Berkanovic E, Oster P, Wong WK, Bulpitt K, Clements P, Sterz M, Paulus H.
    Arthritis Care Res; 1996 Dec; 9(6):257-62. PubMed ID: 9136289
    [Abstract] [Full Text] [Related]

  • 58. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices.
    Griffiths B, Mosca M, Gordon C.
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):685-708. PubMed ID: 16150398
    [Abstract] [Full Text] [Related]

  • 59. Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus.
    Utset TO, Fink J, Doninger NA.
    J Rheumatol; 2006 Mar; 33(3):531-8. PubMed ID: 16511923
    [Abstract] [Full Text] [Related]

  • 60. The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohort.
    Peschken CA, Katz SJ, Silverman E, Pope JE, Fortin PR, Pineau C, Smith CD, Arbillaga HO, Gladman DD, Urowitz M, Zummer M, Clarke A, Bernatsky S, Hudson M, Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS).
    J Rheumatol; 2009 Jun; 36(6):1200-8. PubMed ID: 19369456
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.